Monday, October 1, 2012
"...If the latest trials on breast and other tumors are successful, the drug could become a cheap weapon in the fight against a myriad of diseases including pancreatic and ovarian cancers. All told, cancer kills one in eight people and is the second-leading cause of death in most developed nations."
"“It is safe and it is cheap,” said Donghui Li, an epidemiologist and professor of medicine at the center. “It reduces the risk and has better survival” in studies she’s done in pancreatic cancer patients.
Patients who had taken metformin had a 60 percent lower risk of developing pancreatic cancer, according to a case- control study Li published in 2009 in which she compared cancer patients taking metformin against people not on metformin.
Metformin didn’t benefit patients whose pancreatic cancer had already spread to other tissues, Li reported this year in the journal Clinical Cancer Research. Those patients whose malignancies were confined to the pancreas survived longer if they were on metformin -- an average of 15 months, or four months more than patients not taking the drug, she found.
More research is needed to confirm those benefits in patients as their disease is developing, Li said."
If you'd like to read more about Metformin, you can click here.